Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Frailty in Senior Cancer Patients: Feasibility and Value of Screening Tools and Geriatric Intervention and Predictive Value of a Screening Tool in Relation to Treatment Outcome

NCT01005693 is registered in ClinicalTrials.gov with Ziekenhuis Netwerk Antwerpen (ZNA) as lead sponsor.

NCT NCT01005693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01005693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Frailty in Senior Cancer Patients: Feasibility and Value of Screening Tools and Geriatric Intervention and Predictive Value of a Screening Tool in Relation to Treatment Outcome
Lead sponsor
Ziekenhuis Netwerk Antwerpen (ZNA)
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2009
Completion date
Not reported
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific